Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

HHALOZYME THERAPEUTICS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
H

HALOZYME THERAPEUTICS, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

News

News

  • Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033
    Sep 18, 2026Halozyme Therapeutics, Inc. Press Releases
  • Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033
    Sep 16, 2026Halozyme Therapeutics, Inc. Press Releases
  • Halozyme to Participate at Upcoming Investor Conferences
    Sep 2, 2026Halozyme Therapeutics, Inc. Press Releases
  • Halozyme Appoints Dannielle Appelhans to its Board of Directors
    Aug 18, 2026Halozyme Therapeutics, Inc. Press Releases
  • HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE
    Aug 6, 2026Halozyme Therapeutics, Inc. Press Releases
  • Halozyme to Report Second Quarter 2026 Financial and Operating Results
    Jul 23, 2026Halozyme Therapeutics, Inc. Press Releases
  • Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology
    Jul 20, 2026Halozyme Therapeutics, Inc. Press Releases
  • Halozyme Appoints David Ramsay as President Drug Delivery
    Jun 30, 2026Halozyme Therapeutics, Inc. Press Releases
  • Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029
    Jun 15, 2026Halozyme Therapeutics, Inc. Press Releases
  • HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE
    May 11, 2026Halozyme Therapeutics, Inc. Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions